Innokeys was founded in 2012 by two senior professionals in pharmaceutical Indutries, Johannes Setijono and Rikrik Ilyas. Innokeys Vision and Mission. Innokeys’ mission is to provide value-added innovations in biopharmaceuticals to become a global player with significant contributions in fulfilling unmet medical needs. Our values. We adopt innovative ways of thinking and doing things for a sustainable growth. We are agile to overcome various uncertainties and we always strive for excellence. Product Website www.nimotuzumab.com www.theracim.com Websites of Licensor: CIMAB http://www.cimab-sa.com Websites of Licencees Daiichi Sankyo (Japan) www.daiichisankyo.com Innogene Kalbiotech (Asean, Taiwan, South Africa, Nigeria, Congo) http://www.innogene-kalbiotech.com innokeys_logoInnokeys Pte Ltd (Australia, Canada, USA) http://www.innokeys.com/ Screen Shot 2013-12-11 at 4.28.57 pmKuhnil Pharmaceuticals (Korea) http://www.kuhnil.com/english/sub_01/index2.htm medisonMedison Pharma (Israel) http://www.medison.co.il Oncoscience AG (Europe, Russia) http://www.oncoscience-ag.de/de/index.htm Tearai Biofarma (New Zealand) www.tearaibiofarma.co.nz